Crossmark

Targeted immunotherapy rescues pulmonary fibrosis by reducing activated fibroblasts and regulating alveolar cell profile

Crossref DOI link: https://doi.org/10.1038/s41467-025-59093-7

Published Online: 2025-04-21

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Yan, Jing https://orcid.org/0000-0003-3671-7399
Wang, Song-Yu https://orcid.org/0009-0001-6484-8153
Su, Qi https://orcid.org/0009-0000-2765-0458
Zou, Min-Wen https://orcid.org/0009-0009-5127-5999
Zhou, Zi-Yue https://orcid.org/0009-0002-4488-4744
Shou, Jian

Huo, Yunlong https://orcid.org/0000-0003-4121-3224
License Information

Text and Data Mining valid from 2025-04-21

Version of Record valid from 2025-04-21
More Information

Article History

Received: 10 June 2024

Accepted: 9 April 2025

First Online: 21 April 2025

Competing interests

: The authors declare no competing interests.